ABEONA THERAPEUTICS INC. Other Current Liabilities
ABEONA THERAPEUTICS INC. (ABEO) had Other Current Liabilities of $2.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-03-17
- 2025-12-31: Other Liabilities, Current $2.00K.
- 2025-09-30: Other Liabilities, Current $35.00K.
- 2025-06-30: Other Liabilities, Current $80.00K.
- 2025-03-31: Other Liabilities, Current $317.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2025-12-31 | $2.00K 10-K · filed 2026-03-17 |
| 2025-09-30 | $35.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $80.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $317.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $64.00K 10-K · filed 2026-03-17 |
| 2024-09-30 | $1.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $1.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $199.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $205.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $205.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $204.00K 10-K · filed 2024-03-18 |
| 2021-12-31 | $296.00K 10-K · filed 2023-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |